Regeneron beats quarterly estimates on eczema drug demand; launches dividend program
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
Regeneron: Q4 Earnings Snapshot
The Tarrytown, New York-based company said it had net income of $8.06 per share. Earnings, adjusted for stock option expense and non-recurring costs, came to $12.07 per share. The results exceeded ...
DEADLINE REMINDER: Berger Montague Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Important Class Action Lawsuit Deadline
On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...
Nasdaq20d
What to Expect From Regeneron Pharmaceuticals' Q4 2024 Earnings Report
With a market cap of $77.3 billion, Regeneron Pharmaceuticals ... cutting-edge science to improve patient outcomes. The Tarrytown, New York-based company is expected to unveil its fiscal ...
Regeneron Science Talent Search scholars: Long Island has 49 semifinalists, more than any other U.S. region
Chen was one of 49 Long Island high school seniors named semifinalists Wednesday in the Regeneron contest, the country’s most ...
Regeneron Pharmaceuticals (REGN) Investor Alert: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...
Regeneron Q4 Earnings: Dividend And Dupixent Drive Solid Quarter - Eylea To Strike Back In 2025
Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...
U.S. News & World Report24d
Truveta Sells Stakes to Regeneron, Illumina in Deal to Build Genetic Database
NEW YORK (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will take a $320 million stake in the company as part ...